INTRODUCTION
============

Although groups of fungi are part of the commensal skin microbiota, various species are also pathogenic. It has been estimated that 20--25% of the world population is affected by fungal skin infections. *Candida* species are the second factors of dermatomycoses ([@B1]). Cutaneous *Candida* infections may occur in patients with HIV/AIDS, cancer, receiving chemotherapy, antibiotics, steroid therapy and solid organ transplantation ([@B2]).

During recent years, in different geographical parts, due to patients predisposing conditions and the types of antifungal agents received, changes in species distribution of *Candida* have also happened. Changes in species distribution may impact treatment recommendations because of differences in susceptibility to these antifungals among these species ([@B3]). Previous exposure to antifungals is clearly associated with a shift in species distribution and MICs of available antifungal agents ([@B4]).

The previous data clearly showed that the selection and optimization of an antifungal regimen in treating *Candida* infections are based on multiple factors such as knowledge of local epidemiological data to guide experiential therapy as well as both species identification and antifungal susceptibility testing ([@B5], [@B6]).

Although *Candida albicans* is the most prevalent species involved in cutaneous candidiasis, there has been an increase in the number of non-*Candida albicans* species (NCA), globally. This fact is essentially due to the rise in antimicrobial resistance and the restricted number of competent antifungal drugs, which still have many side effects ([@B7]).

The pathogenicity of *Candida* species is attributed to certain factors, such as the ability to evade host defences by filamentous forms, biofilm formation capacity, and the production of tissue damaging hydrolytic enzymes such as phospholipase ([@B8]).

Typing strains within a microbial species on the basis of DNA sequences at multiple loci has greatly advanced study of the epidemiology and evolutionary phylogenetic of many fungal pathogens ([@B7]). The ability to discriminate between fungal strain types has been a topic of great importance to epidemiologists. The MLST approach offers a number of advantages for studying the geographic distribution, prevalence diversity, genetic basis of pathogenicity, and drug resistance of *Candida* species ([@B9], [@B10]).

The aim of the present study was to evaluate Molecular epidemiology, phylogeny and distribution of *Candida*-related infections with special reference to antifungal susceptibility of identified *Candida* species to current antifungals and their ability to produce virulence factors which facilitate the fungal pathogenicity.

MATERIALS AND METHODS
=====================

Clinical samples and species identification.
--------------------------------------------

During our study, 120 cases suspected to cutaneous candidiasis who referred to our Department of Medical Mycology, Pasteur Institute of Iran were studied. Clinical samples were prepared and examined directly according to the standard protocols and inoculated on the Sabouraud dextrose agar with Chloramphenicol (SC) (Merck, Germany) and incubated at 28°C for one week and 16% were positive. Confirmation and species identification of isolates was done by combination of micromorphological features (germ tube test, morphology on corn meal agar), chromogenic assay on CHROMagar *Candida* (CHROMagar Candida, France), biochemical tests such as API ID32C system (bioMèrieux, Marcy l'Etoile, France) and ITS sequencing according to the manufacturer's instructions. Standard strains of *C. krusei* ATCC (American type culture collection) 6258 was used for quality control.

Molecular identification of *Candida* species: PCR amplification.
-----------------------------------------------------------------

For DNA extraction, fresh colonies were collected upon culturing the isolates on Sabouraud dextrose agar (SDA) for 48 h at 37°C. Genomic DNA was extracted using the Molecular Biology kit (Bio Basic Inc, Canada) according to the manufacturer's instructions and stored at −20°C until used. The molecular identification was performed by sequencing the internal transcribed spacer (ITS) region with ITS1 (5′-TCCGTAGGTGAACCTGCGG-3′) and ITS4 (5′-TCCTCCGCTTATTGATATGC-3′) primers as previously described by Bitar et al. ([@B11]).

DNA sequencing.
---------------

The amplicons were purified and the subsequent sequencing reaction was performed using Big Dye Terminator version 3.1 Cycle Sequencing Kit (Applied Biosystems) on an ABI PRISM 377 Genetic Analyzer (Applied Biosystems). Nucleotide sequences were edited and defined by alignment of forward and reverse sequences using Sequencher 5.4.6 and MEGA version 7.0. To perform the phylogenetic analysis, ITS sequences from type strains were downloaded from GenBank (<http://www.ncbi.nlm.nih.gov/genbank/>) after BLASTn searches (<http://www.ncbi.nlm.nih.gov/>). Phylogenic analyses were conducted by maximum likelihood algorithms. The robustness of the phylogeny was evaluated using 1000 bootstrap replications ([Fig. 1](#F1){ref-type="fig"}) ([@B12]).

![ITS Maximum Likelihood tree showing the phylogenetic relationship among *Candida* isolates. Bootstrap percentages from 1000 replicates are shown in each node.](IJM-11-267-g001){#F1}

*In vitro* antifungal susceptibility testing.
---------------------------------------------

Antifungal susceptibility testing was performed by the reference broth microdilution method guidelines and Categorical susceptibility was assessed using the CLSI M27-S4 breakpoints and epidemiological cutoff values (ECVs) where applicable ([@B13]--[@B15]).

Virulence factors.
------------------

The *in vitro* biofilm formation of *Candida* isolates was determined as described by Zago et al. ([@B16]). The metabolic activity of the biofilm was measured by crystal violet (CV) (1% v/v) assay after 48 h of incubation. Based on the average optical densities (ODs) observed, the isolates were classified into three groups showing: (i) low biofilm-forming (OD less than 0.12); (ii) medium biofilm forming (OD of 0.12--0.20), or (iii) high biofilm-forming (OD higher than 0.20). Phospholipase activity was evaluated by method as mentioned by Tsang et al. and Galan-Ladero et al. ([@B17], [@B18]). Suspension with 10^8^ cell/ml was dropped onto each test medium. After 48 h of incubation at 37°C, the diameters of the colonies (a) and the diameters of the precipitation zone around the colonies (b) were measured. The production of the enzyme was designated as Pz = a/b. The following ranges of activity according to Pz index were established: high, Pz = 0.40; medium, Pz = 0.41--0.60; low, Pz = 0.61--0.80; very low, Pz = 0.81--0.99; none, Pz = 1. The Pz index is a reproducible semi-quantitative technique used widely. Pseudohyphae formation was defined as a cell bearing a rounded outgrowth with a length greater than or equal to the diameter of the parent cell, with a constriction at the base. The percentage of cells in pseudohyphae form, against blastopores after 2 h of cell growth in a liquid medium containing equal volume of RPMI 1640 (Sigma) and fetal bovine serum (GIBCO, USA) was determined by microscopy counting as described by Negri et al. ([@B19]).

Multilocus sequence typing (MLST).
----------------------------------

For DNA extraction, fresh colonies were collected upon culturing the isolates on Sabouraud dextrose agar (SDA) for 48 h at 37°C. Genomic DNA was extracted using the Molecular Biology kit (Bio Basic Inc, Canada) according to the manufacturer's instructions and stored at −20°C until used. The seven used consensus gene sets in the MLST analysis were included; AAT1a, ACC1, ADP1, PMI1b, SYA1, VPS13, and ZWF1b. The gene products, chrosomal localization, primer sequences and number of bases analyzed have been presented in detail earlier ([@B20]) as well as the central internet database for global MLST data (<http://calbicans.mlst.net/>). Fragment amplification by PCR was carried out in a 25 μL reaction volume containing 1 μg of genomic DNA. The amplification was performed using the protocol as described by Gammelsrud et al. ([@B21]). The amplicons were purified and the subsequent sequencing reaction was performed using Big Dye Terminator version 3.1 Cycle Sequencing Kit (Applied Biosystems) on an ABI PRISM 377 Genetic Analyzer (Applied Biosystems). The two overlapping strands were aligned using the Sequencher 5.4.6 software (Gene codes Corporation, Ann Arbor, MI, USA) and contigs were constructed. All contigs were analyzed peak-by-peak, and heterozygosity was identified by the presence of two peaks at the same polymorphic loci on both strands.

Allele numbers and diploid sequence types (DSTs) were found in the central MLST database (<http://calbicans.mlst.net/>). Chromatograms for the isolates with new alleles and/or new DSTs were sent to the central MLST database where new numbers were assigned. eBURST analysis was performed using the eBURST software 3.0 ([@B22]). The DSTs were compared to all DSTs included in the consensus MLST database as of July 2018, and divided into eBURST clonal complexes (CC). CC were named with the reference DSTs in concordance to previously described major *C. albicans* clades ([@B23], [@B24]).

Statistical analysis.
---------------------

Results obtained were analyzed using the under Windows SPSS program Version 16.0. One- way ANOVA with the Tukey post-hoc test was used. All tests were performed with a confidence level of 95%.

RESULTS
=======

Isolation and conventional identification of *Candida* species.
---------------------------------------------------------------

Out of 1588 examined patients, 545 cases were showed dermatomycoses. Among them, 110 cases were positive for cutaneous candidiasis. Of which, 88 sample had growth on culture media. *Candida* isolates collected from cutaneous clinical samples, *C. albicans* (39.8%) was the most prevalent species followed by *C. parapsilosis* (32.9%), *C. orthopsilosis* (10.4%), *C. tropicalis* (7.9%) and *C. glabrata* and *C. guilliermondii*, each (4.5%). The mean age of patients was 50.8 years (range: 2 to 88 years), 64.8% were female. The epidemiological characteristics associated with cutaneous candidiasis were shown in [Table 1](#T1){ref-type="table"}. Among cutaneous lesions, the most frequent affected regions were the nails (64 cases; 72.7%), whereas the least affected site was the glabrous skin region (2 cases; 2.3%). The prevalence of onychomycosis caused by *Candida* species was 50 cases (78%) in women and 14 cases (22%) in men. Clinical files were available for 53 (69.2%) of patients and type 2 diabetes were the most prevalent predisposing factor. Distribution of *Candida* species by anatomical sites of infection were shown in [Table 2](#T2){ref-type="table"}. The most prevalent cause of nail infections was *C. parapsilosis*, whereas in *C. albicans* was the main etiologic agent of hands infection.

###### 

Epidemiological characteristics associated with cutaneous candidiasis

  **Parameter**                 **Candidiasis No. (%)**
  ----------------------------- -------------------------
  **Anatomic sites**            
  Fingernails                   49 (55.7)
  Toenails                      15 (17.0)
  Hands                         13 (14.8)
  Feet                          6 (6.8)
  Groins                        3 (3.4)
  Glabrous skin                 2 (2.3)
  **Species**                   
  *C. albicans*                 35 (39.8)
  *C. parapsilosis*             29 (32.9)
  *C orthopsilosis*             9 (10.4)
  *C. tropicalis*               7 (7.9)
  *C. glabrata*                 4 (4.5)
  *C. guilliermondii*           4 (4.5)
  **Gender**                    
  Female                        57 (64.8)
  Male                          31 (35.2)
  **Age**                       
  0--29                         16 (18.2)
  30--59                        47 (53.4)
  60--89                        25 (28.4)
  **Predisposing factors**      
  Diabetes                      25 (28.4)
  immunosuppressive treatment   15 (17.0)
  rheumatoid arthritis          10 (11.4)
  Other factors                 3 (3.4)
  None                          35 (39.8)
  **Total**                     88 (100)

###### 

Distribution of *Candida* species among clinical specimens.

  **Species**           **Anatomic sites**                                               
  --------------------- -------------------- ---------- ----------- ---------- --------- ----------
  *C. albicans*         9 (18.3)             5 (33.3)   12 (92.3)   5 (83.3)   3 (100)   1 (50.0)
  *C. parapsilosis*     19 (38.8)            8 (53.3)   1 (7.7)     1 (16.7)   0 (0)     0 (0)
  *C. orthopsilosis*    9 (18.3)             0 (0)      0 (0)       0 (0)      0 (0)     0 (0)
  *C. tropicalis*       7 (14.3)             0 (0)      0 (0)       0 (0)      0 (0)     0 (0)
  *C. glabrata*         3 (6.1)              0 (0)      0 (0)       0 (0)      0 (0)     1 (50.0)
  *C. guilliermondii*   2 (4.2)              2 (13.4)   0 (0)       0 (0)      0 (0)     0 (0)
  Total                 49 (100)             15 (100)   13 (100)    6 (100)    3 (100)   2 (100)

Values are given as n (%).

Molecular identification.
-------------------------

Identification of species by conventional methods was confirmed by typing of ITS genes in most cases and all of the *C. orthopsilosis* isolates were detected by this method, exclusively. No *C. metapsilosis* strains were found. The evolutionary relationships of taxa were presented in [Fig. 1](#F1){ref-type="fig"}. The evolutionary history was inferred using the Maximum Liklihood method.

Antifungal susceptibility testing.
----------------------------------

The range of susceptibility according to M27-S4 and ECVs, MIC ranges and geometric means of *Candida* species for the six antifungal agents consistent with CLSI standard documents were summarized in [Table 3](#T3){ref-type="table"}. Majority of the isolates were susceptible to amphotericin B (91.5%), followed by posaconazole (90.3%), fluconazole (84.3%), itraconazole (74.1%), caspofungin (53.6%), and voriconazole (26.8%).

###### 

*In vitro* susceptibility testing of *Candida* species to seven antifungal agents determined by CLSI broth microdilution method

  **Species (No.)**         **Antifungal drug**   **MIC Range (μg/mL)**   **Susceptibility (%)**   **Geometric mean**                          
  ------------------------- --------------------- ----------------------- ------------------------ -------------------- ------ ------ -------- ---------
  *C. albicans* (35)        FCZ                   0.012--2                100                      0                    0      82.0   18.0     0.2928
  VOR                       0.062--8              71.4                    8.6                      20.0                 72.2   27.8   0.2264   
  ITR                       0.062--4              51.4                    14.3                     34.3                 51.4   48.6   0.2133   
  POS                       0.031--16             \-                      \-                       \-                   88.6   11.4   0.0509   
  CAS                       0.031--4              48.6                    37.1                     14.3                 22.9   77.1   0.4018   
  AmB                       0.031--2              \-                      \-                       \-                   100    0      0.3781   
  KCZ                       0.031--4              \-                      \-                       \-                   \-     \-     0.0905   
  *C. parapsilosis* (29)    FCZ                   0.12--2                 100                      0                    0      100    0        0.0704
  VOR                       0.062--2              24.1                    13.8                     62.1                 24.1   75.9   0.3171   
  ITR                       0.062--2              \-                      \-                       \-                   93.1   6.9    0.2325   
  POS                       0.031--0.062          \-                      \-                       \-                   100    0      0.0499   
  CAS                       0.062--8              96.6                    3.4                      0                    89.7   10.3   0.5500   
  AmB                       0.12--4               \-                      \-                       \-                   96.0   4.0    0.3869   
  KCZ                       0.031--1              \-                      \-                       \-                   \-     \-     0.1027   
  *C. orthopsilosis* (9)    FCZ                   0.25--4                 \-                       \-                   \-     88.0   12.0     0.9258
  VOR                       0.25--2               \-                      \-                       \-                   0      100    0.7348   
  ITR                       0.12--2               \-                      \-                       \-                   \-     \-     0.4286   
  POS                       0.031--0.12           \-                      \-                       \-                   100    0      0.0725   
  CAS                       0.031--2              \-                      \-                       \-                   55.6   44.4   0.6293   
  AmB                       0.12--2               \-                      \-                       \-                   \-     \-     0.7058   
  KCZ                       0.062--0.5            \-                      \-                       \-                   \-     \-     0.1455   
  *C. glabrata* (4)         FCZ                   0.25--64                0                        25.0                 75.0   75.0   25.0     2.16653
  VOR                       2--8                  \-                      \-                       \-                   0      100    2        
  ITR                       0.5--1                \-                      \-                       \-                   100    0      0.7262   
  POS                       0.031--0.12           \-                      \-                       \-                   100    0      0.1331   
  CAS                       0.031--1              25.0                    75.0                     0                    25.0   75.0   0.1384   
  AmB                       0.031--2              \-                      \-                       \-                   80.0   20.0   0.4494   
  KCZ                       0.12--4               \-                      \-                       \-                   \-     \-     0.4868   
  *C. guilliermondii* (4)   FCZ                   0.062--8                \-                       \-                   \-     75.0   25.0     0.7071
  VOR                       0.062--4              \-                      \-                       \-                   50.0   50.0   0.4204   
  ITR                       0.062--0.5            \-                      \-                       \-                   100    0      0.2973   
  POS                       0.12--16              \-                      \-                       \-                   75.0   25.0   0.4204   
  CAS                       0.25--1               100                     0                        0                    100    0      0.3535   
  AmB                       0.12--1               \-                      \-                       \-                   100    0      0.2973   
  KCZ                       0.031--0.5            \-                      \-                       \-                   \-     \-     0.1487   
  *C. tropicalis* (7)       FCZ                   0.25--16                85.7                     14.3                 0      85.7   14.3     0.7430
  VOR                       0.062--1              14.3                    28.6                     57.1                 14.3   85.7   0.4102   
  ITR                       0.062--0.5            \-                      \-                       \-                   100    0      0.2050   
  POS                       0.031--0.25           \-                      \-                       \-                   85.7   14.3   0.0690   
  CAS                       0.12--4               57.1                    28.6                     14.3                 28.6   71.4   0.4102   
  AmB                       0.062--4              \-                      \-                       \-                   70.0   30.0   0.6095   
  KCZ                       0.062--0.25           \-                      \-                       \-                   \-     \-     0.1250   

MIC: Minimum Inhibitory Concentration, (-) breakpoints not provided by CLSI documents, FCZ: Fluconazole, VOR: Voriconazole, ITR: Itraconazole, POS: Posaconazole, CAS: Caspofungin, AmB: Amphotericin B, KCZ: Ketoconazole, CBP: clinical breakpoints, ECV: epidemiological cutoff values, WT: wild type, S: susceptible, R: resistant and SDD: susceptible dose dependent.

The present results revealed a statistically significant difference in the susceptibility of *C. albicans* and NCA to AmB (P \< 0.02).

Virulence factors.
------------------

The isolates tested exhibited various degrees of phospholipase activity (Pz value: 0.42--1). A total of 20 (57.1%) of the 35 *C. albicans* isolates and 40 (75.5%) of the 53 NCA strains exhibited phospholipase activity (P\<0.05). The biofilm production was also evaluated in the 83 isolates (94.3%). Biofilm production by *C. albicans* isolates was lower than that by NCA isolates (91.4% vs. 96.2%) respectively (P\<0.05). The highest phospholipase activity, biofilm formation and pseudohyphae production were seen in *C. parapsilosis* isolates ([Fig. 2](#F2){ref-type="fig"}).

![Comparison of virulence factors capacity of *Candida* species, (a): phospholipase activity; high, Pz = 0.40; medium, Pz = 0.41--0.60; low, Pz = 0.61--0.80; very low, Pz = 0.81--0.99; none, Pz = 1, (b): biofilm formation ability; low, (OD less than 0.12); medium, (OD of 0.12--0.20), or high, (OD higher than 0.20), (c): pseudohyphae construction; very low, (1--20)%; low, (30--50)%; medium, (50--80)% and high, (80--100)%.](IJM-11-267-g002){#F2}

Multilocus sequence typing (MLST).
----------------------------------

The MLST data of the 35 *C. albicans* isolates consisted of 2883 nt distributed in 4 major clades ([Fig. 3](#F3){ref-type="fig"}). Eighty eight alleles were identified in the seven loci studied. The gene VPS13 generated the highest number of alleles (n=18), while MPb1 generated the lowest number (n=6). Among the alleles, seven new alleles were determined. There were in the ADP1 locus (allelic numbers 171 and 172), VPS13 (303, 304 and 305) and ZWF1b (293 and 294). These were added to the MLST database (<http://calbicans.mlst.net>). The 35 isolates yielded 33 unique Diploid Sequence Type (DSTs). Seven isolates (20.0%) belonged to previously described DSTs, while 28 (80.0%) were new. Three isolates were assigned to DST 1403. [Table 4](#T4){ref-type="table"} shows the allelic number for each gene and DST for all the strains included in the study. Of 35 isolates, 24 (68.5%) clustered into previously known CC, while 11 (31.5%) did not cluster in any known group. The major of isolates were grouped into three CC: 124 (20%), 461 (17.2%) and 918 (14.3%). Seventeen of the new DST clustered among already defined CCs (61%), however, 11 (39%) of the new DST could not be assigned to any known CC.

![The dendrogram was constructed from UPGMA analysis based on concatenated MLST sequence of the seven loci of 35 *C. albicans* strains. Site of isolation, gender, age and clade assignments were indicated in the right columns.](IJM-11-267-g003){#F3}

###### 

Alleles, Diploid Sequence Types (DSTs) and clonal clusters for the *Candida* strains included in the study. Bold numbers are the new alleles or DST assigned by the curator of MLST database.

  **Strain no.**   **AAT1a**   **ACC1**   **ADP1**   **MP1b**   **SYA1**   **VPS13**   **ZWF1b**   **DST**   **Clonal cluster**
  ---------------- ----------- ---------- ---------- ---------- ---------- ----------- ----------- --------- --------------------
  93-62            62          3          46         3          3          215         95          3492      S
  93--107          6           3          37         2          38         303         12          3493      840
  93--135          8           14         8          4          34         10          8           3494      124
  93--360          60          7          8          1          34         11          15          3495      461
  93--405          6           3          3          2          38         10          12          3496      S
  93--406          62          3          3          3          3          115         94          3497      918
  93--407          62          3          3          14         3          115         95          3498      918
  93--475          62          3          43         3          3          115         95          3499      918
  93--664          13          3          8          4          34         20          8           3500      S
  93--666          6           3          10         2          153        304         12          3501      S
  93--690          60          10         3          1          34         11          15          3502      461
  93--751          60          13         96         1          34         11          15          3503      461
  93--829          47          14         35         28         18         213         6           3504      S
  93--902          60          10         171        1          34         11          15          3505      461
  93--912          8           14         8          4          50         10          8           1403      124
  93--959          6           3          6          4          173        72          202         3506      S
  93--1095         8           7          8          4          2          3           8           3507      124
  93--1167         8           14         8          4          50         10          8           1403      124
  93--1173         6           3          172        2          125        305         12          3508      S
  93--1242         3           3          5          3          57         130         6           3509      367
  93--1361         8           14         8          4          7          10          293         3510      124
  93--1428         62          3          3          3          26         39          95          1103      918
  93--1471         8           14         8          4          50         10          8           1403      344
  93--1489         14          14         8          4          2          10          8           3511      124
  93--1598         28          10         154        1          34         126         294         3512      S
  93--1646         62          3          3          3          3          39          95          918       918
  93--1659         8           14         8          4          2          3           8           481       124
  93--1670         60          10         21         1          34         11          15          2216      461
  93--1849         62          12         21         1          6          30          72          3513      538
  93--1878         2           3          6          2          2          265         261         3514      S
  93--1911         60          13         21         1          34         126         15          3515      461
  93--2381         13          3          37         2          153        126         12          3516      S
  93--2553         62          12         6          1          6          30          7           3517      538
  93--2612         23          5          5          2          2          20          25          3518      S
  93--2845         80          3          6          4          30         45          1           3519      747

S; singleton

DISCUSSION
==========

In the present study, cutaneous isolates of six *Candida* species (16% of cases with cutaneous candidiasis) were reported in outpatients referred to our laboratory. The prevalence of candidiasis was found to be different in various gender and age groups. In accordance with reports by Heidrich et al., women were more affected than men ([@B25]). The most frequent site of candidiasis in both genders was nail. Overall, the prevalence of cutaneous candidiasis has globally increased over the past years. The etiological pathogens and main infection sites vary according to the geographical region. It has been related that more than 90% of onychomycosis caused by yeasts, and their prevalence worldwide is up to 29% ([@B25]). This is in agreement with the results from other parts of world such as Iran by Hamedifard et al. in Tehran ([@B26]). In our study, the incidence of onychomycosis by *Candida* isolates (72.7%) were more than that report by Afshar et al. (61.9%) ([@B27]). Our results in the epidemiological alteration in distribution of *Candida* species were shown increase in prevalence of *C. albicans* and *C. parapsilosis* isolates but decrease in *C. tropicalis* and *C. guilliermondii* in comparison with the previous study in Guilan ([@B28]).

Onychomycosis was the most prevalent in the age group 50--59 years. Our results were in contrast to reports from northeast of Iran with the rate of 1.6% cutaneous candidiasis and the most prevalence of infections in the age range of 20--29 years ([@B29]).

We found some correlation among genotyping of *Candida* isolates and clinical features in phylogeny groups obtained by ITS sequencing. Whereas the cause of all of candidiasis in groins and in children was *C. albicans*, it played a minor role in onychomycosis (21.8%). All of *C. albicans* isolates were resistant to CAS. While all of the high quality of biofilm formation of *C. albicans* was shown in one clade with 31 isolates, other 4 *C. albicans* strains were medium in this ability. Each of *C. tropicalis*, *parapsilosis* and *guilliermondii* species were identified in one clade, separately. The 65.5% of *C. parapsilosis* isolates were recognized from fingernails specimens and 79% from women. Most of them were found in the age group of 50 to 60 years.

*C. tropicalis* and *C. orthopsilosis* were the causes of candidiasis in women and isolated from, fingernail lesions, exclusively. *C. tropicalis* was detected as the most common agent in the patients aged 40--50 years, whereas, *C. orthopsilosis* predominantly found in the 30--60 years age group.

In this study, the frequency of NCA species was higher (60.2%) than that of *C. albicans* (39.8%), indicating an increase in the frequency of NCA species in Iran. While the emergence of NCA species in various regions of the world is pointing towards a varied change in epidemiological behavior of the disease ([@B30]), these results in comparison with our previous reports, showed a shift from *C. albicans* as the predominant pathogen towards an increasing prevalence of the species *C. parapsilosis* ([@B15]). Similar to reports of Ghasemi et al. ([@B31]) diabetic patients had the highest susceptibility to candidiasis (28.4%).

In accordance with reports by Feng et al. ([@B32]). that *C. orthopsilosis* was isolated from cutaneous samples frequently, suggesting a possible pathogenic role of this species in superficial infections. Contrary to some reports ([@B33]), no *C. metapsilosis* strains were found in the present study.

Changes in *Candida* species distribution may influence treatment recommendations due to differences in susceptibility to antifungal agents among species. While based on the results reported by Whaley et al. ([@B34]), in the Asia-Pacific region, fluconazole resistance in *C. tropicalis* ranges from 0 to as high as 83% and the worldwide incidence of fluconazole resistance in *C. parapsilosis* disseminated infections ranges between 2 and 5%, our *C. parapsilosis* and *C. tropicalis* isolates were susceptible to fluconazole completely (P\<0.04). All of our isolates were susceptible to amphotericin B, posaconazole and itraconazole (P\< 0.01). Whereas the results obtained in this study corroborate previous findings in Iran ([@B35]), there was some modification in the rate of resistance to antifungals that is possibly due to the use of over the counter azole agents ([@B13]). According to susceptibility pattern of our *Candida* species obtained in this study, the best three antifungals were amphotericin B, posaconazole and fluconazole, respectively.

Recent evidence suggests that the majority of infections produced by these pathogens are associated with biological factors such as biofilm growth, phospholipase activity and pseudohyphae formation. Biofilm formation was found to occur most frequently among NCA (96.2%) than *C. albicans* (91.4%). This result was in accordance with published reports from India, Brazil and Saudi Arabia ([@B36]). There was significant difference in the biofilm forming abilities between *C. parapsilosis* and other *Candida* isolates. Phospholipase play an important role in the growth of *Candida* spp. and subsequent invasion of the host. Besides, although there has been widespread research to identify pathogenic factors in fungi, mainly in *C. albicans*, little is known about NCA isolates. Although a few studies of phospholipase activity have been undertaken for *C. tropicalis* and *C. parapsilosis*, none has been reported for other strains. Our finding was concurring with the results of previous investigations, in higher percentage of phospholipase production (53.8--74%) by *C. albicans* isolates, and in contrast to these results in NCA isolates (2--17%) ([@B37]). In the current study, the phospholipase activity of *C. albicans* was lower as compared to the NCA isolates except for *C. guilliermondii* strains. Whereas our results about higher percentage of positive phospholipase activity in NCA isolates were in accordance with Junior et al that *C. tropicalis* was reported as the highest number of positive isolates (91.7%) ([@B38]), in our finding *C. parapsilosis* was the most. Although *C. parapsilosis* demonstrated high pathogen factors capability such as pseudohyphae production, in agreement with Negri et al. ([@B19]) we did not find a clear relation between their abilities.

Molecular typing is a valuable method generally used for evaluating the genetic similarity of isolates in applied epidemiology. We used MLST to illustrate the genetic diversity and population structure of our *C. albicans* isolates through the public central database.

In our study, the profiles included five previously reported DSTs from UK by Odd et al in 2014 including 1403, 1103, 918, 481 and 2216. Three strains with the same DST (1403) were identified. Because of the greater number of isolates, the percentage of new DSTs in this study was 80.0% (28 out of 35) and higher than other studies published from Iran previously, such as the one performed by Afsarian et al. ([@B39]) reported 10 novel DSTs for *C. albicans* isolates from a burn intensive care unit in Iran. Similar to this report, CC 124 was the most frequent but its portion was decreased. Whereas, previous reports by Alastruey-Izquierdo et al. ([@B40]), showed CC 124 was the most prevalent in superficial candidiasis isolates but CC 918 was only found in candidemia strains ([@B40]), in our study, CC 124 also were the most and CC 918 the second. These differences can be due to the origin (both geographical and clinical) of the strains included in the data base. For analysis of this kind of assay, the larger group of isolates is necessary. We recognized 28 new DSTs (80%). Seventy-eight percent of our isolates clustered within 4 (i.e. 1,4, 9, 11) of the 18 known clades that fifty-eight percent of them belonged to three of five major clades (i.e. clades 1, 4, 11) as defined previously ([@B23]). Totally, 6% of isolates belong to clade 1, 29% of isolates to clade 11, 23% to clade 4 and 20% to clade 9, respectively. After 9 years, our results were differing from previous reports by Odds et al in 2007 and 2010 that clade 1 was the most prevalent one followed by clade 4, and clade 11, respectively ([@B23]). The ratio of clade 1 and 4 in our isolates were less than what reported by Afsarian et al. (2015) whereas this proportion about clade 9 was more. In comparison to previous report from Iran in 2015, clade 12 and 15 were not identified. Ge et al. (2012) found even higher percentages (79%) of new DSTs in strains isolated from superficial samples in China ([@B40]). Three new DSTs, including 3497, 3498 and 3499, assigned to CC 918, were found to be different in three loci from DSTs 918 and 1103 ([Table 4](#T4){ref-type="table"}). These findings may suggest micro evolutionary changes of a single strain occurring during adaptation to varying environmental conditions.

Our results showed that NCA species gained increasing importance as the etiologic agents of cutaneous *Candida* infections specially onychomycosis in Iran. Among tested antifungals, the best three antifungals were amphotericin B, posaconazole and fluconazole. As causative agents in candidiasis vary according to geographical area, treatment should be based on studies carried out regularly in the same regions through well-planned studies. Our results clearly indicate the importance of antifungal susceptibility testing as a necessity to select the drug of choice for treatment of different forms of candidiasis to overcome treatment failure and drug resistance phenomenon. We showed that NCA isolates particularly *C. parapsilosis* were more pathogenic than that of *C. albicans* isolates. According to MLST results, 28 novel sequence types with 11 singletons were reported for *C. albicans* strains with around 80% of new DSTs. Further whole genome sequencing of multiple *C. albicans* isolates from different clades, geographical locations and anatomical sources should provide further useful information regarding virulence gene family expansions and molecular epidemiology of this species.
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